Index S&P 500
P/E -
EPS (ttm) -9.10
Insider Own 11.44%
Shs Outstand 255.70M
Perf Week -1.71%
Market Cap 22.17B
Forward P/E 19.08
EPS next Y 4.58
Insider Trans -0.02%
Shs Float 226.43M
Perf Month -2.73%
Income -2318.00M
PEG -
EPS next Q 0.82
Inst Own 80.77%
Short Float 1.90%
Perf Quarter -15.67%
Sales 11.42B
P/S 1.94
EPS this Y 25.52%
Inst Trans -2.19%
Short Ratio 3.07
Perf Half Y -7.55%
Book/sh 57.78
P/B 1.51
EPS next Y 9.29%
ROA -7.32%
Short Interest 4.31M
Perf Year 11.01%
Cash/sh 2.24
P/C 39.10
EPS next 5Y 10.00%
ROE -14.60%
52W Range 72.94 - 106.77
Perf YTD 7.94%
Dividend Est. 1.64 (1.87%)
P/FCF 23.97
EPS past 5Y -
ROI -9.65%
52W High -18.14%
Beta 1.19
Dividend TTM 2.01 (2.30%)
Quick Ratio 1.93
Sales past 5Y 31.28%
Gross Margin 29.52%
52W Low 19.82%
ATR (14) 1.72
Dividend Ex-Date Dec 20, 2024
Current Ratio 2.62
EPS Y/Y TTM -5139.41%
Oper. Margin 9.51%
RSI (14) 32.21
Volatility 1.66% 1.80%
Employees 21500
Debt/Eq 0.66
Sales Y/Y TTM -1.76%
Profit Margin -20.30%
Recom 1.87
Target Price 104.79
Option/Short Yes / Yes
LT Debt/Eq 0.63
EPS Q/Q 135.01%
Payout -
Rel Volume 0.82
Prev Close 88.10
Sales Surprise 3.28%
EPS Surprise -3.11%
Sales Q/Q 3.72%
Earnings Nov 05 AMC
Avg Volume 1.40M
Price 87.40
SMA20 -2.06%
SMA50 -8.37%
SMA200 -7.29%
Trades
Volume 1,157,156
Change -0.79%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-12-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$111 → $110
Nov-08-24 Upgrade
BofA Securities
Neutral → Buy
$107
Nov-07-24 Upgrade
Vertical Research
Hold → Buy
$109
Sep-11-24 Reiterated
Oppenheimer
Outperform
$116 → $117
Sep-03-24 Upgrade
Mizuho
Neutral → Outperform
$109 → $120
Jul-22-24 Upgrade
Stifel
Hold → Buy
$95 → $115
Jun-07-24 Initiated
Oppenheimer
Outperform
$116
May-21-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$100
May-08-24 Upgrade
JP Morgan
Neutral → Overweight
$75 → $100
Apr-18-24 Upgrade
Barclays
Underweight → Equal Weight
Apr-10-24 Upgrade
Citigroup
Neutral → Buy
$81 → $100
Mar-08-24 Downgrade
Argus
Buy → Hold
Mar-01-24 Initiated
Wolfe Research
Underperform
Jan-22-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$81 → $90
Jan-12-24 Upgrade
Jefferies
Hold → Buy
$73 → $112
Nov-28-23 Upgrade
Argus
Hold → Buy
Nov-13-23 Downgrade
UBS
Buy → Neutral
$88 → $78
Oct-12-23 Initiated
Redburn Atlantic
Neutral
$60
Aug-24-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112 → $75
Aug-09-23 Downgrade
Goldman
Buy → Neutral
$120 → $78
Show Previous Ratings
Dec-12-24 08:00AM
Dec-10-24 04:15PM
Dec-05-24 11:30AM
Dec-02-24 08:48AM
Nov-20-24 12:36PM
04:00AM
Loading…
Nov-14-24 04:00AM
Nov-12-24 12:13AM
Nov-11-24 09:15AM
Nov-08-24 12:56PM
Nov-07-24 02:01PM
09:35AM
Nov-06-24 04:43PM
12:52PM
12:01AM
Nov-05-24 06:00PM
05:25PM
Loading…
05:25PM
04:32PM
(Associated Press Finance)
04:15PM
Nov-04-24 04:00AM
Oct-31-24 09:15AM
Oct-30-24 04:15PM
Oct-29-24 10:01AM
Oct-24-24 09:00AM
Oct-23-24 01:00AM
Oct-22-24 09:50AM
Oct-21-24 09:00AM
Oct-18-24 11:01AM
Oct-17-24 04:15PM
Oct-16-24 10:08AM
Oct-14-24 09:00AM
06:53AM
Loading…
Sep-28-24 06:53AM
Sep-27-24 11:27AM
Sep-26-24 09:00AM
Sep-24-24 03:16AM
Sep-16-24 09:50AM
Sep-08-24 03:04PM
Sep-07-24 07:53PM
Sep-06-24 12:00PM
Sep-05-24 11:31AM
Sep-02-24 06:23PM
Aug-30-24 06:09PM
Aug-27-24 06:07PM
Aug-15-24 04:15PM
Aug-12-24 09:15AM
Aug-08-24 01:16AM
(Thomson Reuters StreetEvents)
Aug-07-24 04:26PM
02:11PM
Aug-06-24 06:30PM
05:25PM
04:25PM
(Associated Press Finance)
04:15PM
Aug-05-24 09:04AM
Aug-01-24 09:15AM
Jul-30-24 09:00PM
05:08PM
12:19PM
10:01AM
Jul-09-24 04:15PM
Jun-30-24 09:12AM
Jun-28-24 09:50AM
Jun-26-24 04:00AM
Jun-24-24 06:35AM
Jun-12-24 09:50AM
Jun-05-24 11:30AM
May-30-24 04:15PM
04:15PM
May-29-24 04:15PM
May-27-24 06:00AM
May-21-24 12:30PM
12:22PM
May-15-24 09:00AM
May-14-24 04:01PM
May-13-24 08:59AM
May-10-24 09:27AM
May-09-24 06:43AM
May-08-24 03:30PM
11:18AM
11:11AM
08:34AM
08:05AM
07:36AM
07:00AM
06:52AM
06:52AM
06:52AM
05:44AM
03:21AM
01:06AM
May-07-24 11:13PM
(Thomson Reuters StreetEvents) +6.40%
04:48PM
12:47PM
12:42PM
10:29AM
07:43AM
07:39AM
May-06-24 06:12PM
06:00PM
05:55PM
05:30PM
04:58PM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Finzel Ralf EVP, Global Operations Officer Dec 02 '24 Option Exercise 0.00 5,387 0 9,622 Dec 03 04:05 PM Arora Yuvraj President, Nourish Nov 11 '24 Sale 91.75 5,000 458,775 3,238 Nov 12 04:20 PM Arora Yuvraj Officer Nov 11 '24 Proposed Sale 91.75 5,000 458,775 Nov 12 09:07 AM RICHTER GLENN R CFO Oct 01 '24 Option Exercise 0.00 11,812 0 32,171 Oct 03 04:20 PM Borg Deborah EVP, Chief HR and D&I Officer Sep 03 '24 Option Exercise 0.00 13,807 0 30,282 Sep 05 04:05 PM Herriott Simon Pres. Health & Bioscience Jul 03 '24 Option Exercise 0.00 627 0 10,759 Jul 05 04:10 PM Strzelecki Angela President, Pharma Solutions Jun 13 '24 Option Exercise 77.16 2,588 199,690 11,127 Jun 14 04:56 PM Strzelecki Angela President, Pharma Solutions Jun 13 '24 Sale 95.66 2,588 247,560 8,539 Jun 14 04:56 PM Yildiz Beril CAO, SVP & Controller May 03 '24 Option Exercise 0.00 848 0 1,588 May 07 07:06 PM O'Byrne Kevin Director May 03 '24 Option Exercise 0.00 1,671 0 1,933 May 07 07:06 PM Strzelecki Angela President, Pharma Solutions May 03 '24 Option Exercise 0.00 1,060 0 8,868 May 07 07:06 PM Teles de Mendonca Ana Paula President, Scent May 06 '24 Option Exercise 0.00 726 0 1,178 May 07 07:06 PM Teles de Mendonca Ana Paula President, Scent May 03 '24 Option Exercise 0.00 707 0 707 May 07 07:06 PM RICHTER GLENN R CFO May 03 '24 Option Exercise 0.00 4,243 0 21,889 May 07 07:06 PM Johnson Jennifer Amy EVP, General Counsel May 03 '24 Option Exercise 0.00 2,121 0 7,936 May 07 07:04 PM Hu Gaoxiang Director May 03 '24 Option Exercise 0.00 1,671 0 2,105 May 07 07:04 PM Herriott Simon Pres. Health & Bioscience May 03 '24 Option Exercise 0.00 1,591 0 10,625 May 07 07:03 PM Gold Christina A Director May 03 '24 Option Exercise 0.00 1,671 0 10,840 May 07 07:03 PM Finzel Ralf EVP, Global Operations Officer May 03 '24 Option Exercise 0.00 1,326 0 4,770 May 07 07:03 PM Ferguson Roger W. Jr. Director May 03 '24 Option Exercise 0.00 2,625 0 2,625 May 07 06:56 PM DAVIDSON CAROL ANTHONY Director May 03 '24 Option Exercise 0.00 1,671 0 1,926 May 07 06:56 PM Costa Mark J Director May 03 '24 Option Exercise 0.00 1,671 0 2,139 May 07 06:55 PM Bruno Barry A. Director May 03 '24 Option Exercise 0.00 1,671 0 3,205 May 07 06:55 PM Borg Deborah EVP, Chief HR and D&I Officer May 03 '24 Option Exercise 0.00 1,768 0 17,188 May 07 06:55 PM Arora Yuvraj President, Nourish May 03 '24 Option Exercise 0.00 11,538 0 11,538 May 07 06:54 PM Johnson Jennifer Amy EVP, General Counsel Apr 05 '24 Option Exercise 0.00 968 0 6,165 Apr 09 05:28 PM Herriott Simon Pres. Health & Biosci. & Scent Apr 05 '24 Option Exercise 0.00 1,590 0 9,496 Apr 09 05:26 PM Strzelecki Angela President, Pharma Solutions Apr 05 '24 Option Exercise 0.00 1,140 0 8,162 Apr 09 05:25 PM Herriott Simon Pres. Health & Biosci. & Scent Apr 01 '24 Option Exercise 0.00 1,489 0 8,367 Apr 03 04:24 PM Clyburn Frank Chief Executive Officer Mar 01 '24 Option Exercise 0.00 1,324 0 2,170 Mar 05 07:06 PM Strzelecki Angela President, Pharma Solutions Jan 03 '24 Option Exercise 0.00 1,341 0 7,418 Jan 04 04:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite